3107 Elrod Rd, Suite G, Katy, TX 77494
(832) 930-9797
Call Us Schedule
SPRAVATO® Treatment

Depression That Hasn't Improved With Treatment

Major depressive disorder (MDD) doesn't always respond to the first medications tried. If other antidepressants haven't helped enough, SPRAVATO® (esketamine) nasal spray may be an option for eligible adults with treatment-resistant depression (TRD).

QuCiL Health™ is a SPRAVATO® REMS-certified center offering supervised, in-office treatment.

Not sure if this applies to you? An evaluation can help determine whether SPRAVATO® is appropriate for your situation.

Adults 18+  ·  REMS-certified center

SPRAVATO® is also approved, along with an oral antidepressant, for adults with MDD who have thoughts or behaviors of suicide. If you or someone you love is in crisis, call or text 988 or go to the nearest emergency room.
SPRAVATO® treatment at QuCiL Health
Indications

Who SPRAVATO® Is For

SPRAVATO® is an FDA-approved prescription medicine used in adults 18 and older.

Approved Uses

Treatment-Resistant Depression (TRD) For adults with depression that has not improved enough after trying at least two antidepressants.
Major Depressive Disorder (MDD) with Suicidal Thoughts Used together with an oral antidepressant to help adults with MDD who have thoughts or behaviors of suicide.
REMS-Certified Administration SPRAVATO® is available only through the SPRAVATO® REMS restricted program and must be given under medical supervision.
SPRAVATO® treatment at QuCiL Health

Fast Relief in Treatment-Resistant Depression

Unlike conventional antidepressants that may take weeks to show meaningful results, clinical studies of SPRAVATO® have demonstrated improvements in depressive symptoms that can begin within 24 hours of the first treatment. For patients with severe depression, the ability to act quickly matters.

At QuCiL Health™ in Katy, Texas, we offer this treatment under the expert care of Shirley Amanfo, FNP-C, a REMS-certified provider. Our calm, monitored treatment room is designed for your comfort and safety.

FDA-Approved

Insurance-Covered

Fast-Acting

How SPRAVATO® Works

SPRAVATO® targets N-methyl-D-aspartate (NMDA) receptors in the brain — a completely different mechanism than traditional antidepressants that work on serotonin, norepinephrine, or dopamine systems.

Treatment is administered in our certified treatment room. Each session involves self-administration of the nasal spray under medical supervision, followed by a two-hour monitoring period to ensure your safety and comfort.

Medical professional administering SPRAVATO®
Care Guide

Your 4-Step Care Journey

From first evaluation to long-term support — here's what to expect at every step.

01

Initial Consultation & Evaluation

We review your medical history, previous treatments, current medications, and goals to determine whether SPRAVATO® is appropriate for you.

02

Session Scheduling & Administration

Once approved, we schedule your treatment sessions at convenient times. Each visit includes supervised self-administration in our calming treatment room.

03

Tailored Treatment Plan

Your plan is customized to your response and goals — beginning with the induction phase, transitioning to maintenance, then to ongoing care.

04

Ongoing Support

We monitor your progress throughout, adjust treatment as needed, and coordinate with your referring providers for continuity of care.

Treatment Timeline

Your SPRAVATO® Treatment Phases

Treatment is delivered in three structured phases, adjusted to your response and needs.

Phase 1

Induction Phase

Week 1–4

2x Weekly Dosing

Initial intensive phase to build therapeutic effect and establish a foundation for symptom relief and mood stabilization.

Phase 2

Maintenance Phase

Week 5–8

1x Weekly Dosing

Consolidation phase to maintain progress, stabilize mood improvements, and prepare for long-term maintenance.

Phase 3

Ongoing Care

Week 9 onwards

Individualized Schedule

Long-term maintenance with treatments every 1–2 weeks based on your individual response and ongoing needs.

QuCiL Health SPRAVATO® treatment room

Our SPRAVATO® treatment room — designed for comfort, privacy, and 2-hour observation.

Watch Their Stories

Patient Video Testimonials

Hear from real patients about their experience with SPRAVATO® treatment at QuCiL Health.

Patient · Sarah

Sarah's Story

Hear about her experience with SPRAVATO® treatment and the care she received at QuCiL Health.

Patient · Soraya

Soraya's Story

Hear her perspective on SPRAVATO® treatment and the support she felt throughout her care.

Videos play directly on this page. Individual results vary.

Patient Stories

What Our Patients Say

Real experiences from patients who found hope and healing with our care.

"At this clinic, they make you feel like a person and not just the next number. Very cordial medical staff that shows genuine concern and care. The Nurse Practitioner was knowledgeable, understanding, and truly listened to my concerns about my mental health."

M
Micky A.
Patient

"Mrs. Shirley took the time to address all my questions and concerns about my anxiety treatment. The entire experience, from the moment I walked in, was fantastic. I finally feel like I have a provider who understands what I'm going through."

G
Gee B.
Patient

"I have never felt this understood after a doctor's visit. Thank you for listening and providing such compassionate care. It's refreshing to find a provider who truly cares."

A
Ayo Ay1
Patient

Spravato withMe Patient Support Program

The Spravato withMe™ program offers personalized support for patients starting or continuing SPRAVATO® treatment — including insurance guidance, financial assistance information, and treatment-related resources.

Hours: Monday – Friday, 8:00 AM – 8:00 PM ET
Visit Spravato withMe

Not Sure If SPRAVATO® Is Right for You?

An evaluation can help determine whether SPRAVATO® is appropriate for your situation.